Search

Your search keyword '"DI MAIO, R"' showing total 72 results

Search Constraints

Start Over You searched for: Author "DI MAIO, R" Remove constraint Author: "DI MAIO, R" Database MEDLINE Remove constraint Database: MEDLINE
72 results on '"DI MAIO, R"'

Search Results

1. LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson's disease.

2. NADPH oxidase 2 activity disrupts Calmodulin/CaMKIIα complex via redox modifications of CaMKIIα-contained Cys30 and Cys289: Implications in Parkinson's disease.

3. 15-Lipoxygenase-Mediated Lipid Peroxidation Regulates LRRK2 Kinase Activity.

4. High-resolution geoelectrical characterization and monitoring of natural fluids emission systems to understand possible gas leakages from geological carbon storage reservoirs.

5. Neuroprotective actions of a fatty acid nitroalkene in Parkinson's disease.

6. NADPH oxidase 2 activity in Parkinson's disease.

7. The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.

8. LRRK2 and idiopathic Parkinson's disease.

9. Measurement of LRRK2 Kinase Activity by Proximity Ligation Assay.

10. Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents.

11. α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo.

12. Essential Nanostructure Parameters to Govern Reinforcement and Functionality of Poly(lactic) Acid Nanocomposites with Graphene and Carbon Nanotubes for 3D Printing Application.

13. LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease.

14. WIN 55,212-2 Reverted Pilocarpine-Induced Status Epilepticus Early Changes of the Interaction among 5-HT 2C /NMDA/CB 1 Receptors in the Rat Hippocampus.

15. Synergistic action of CB 1 and 5-HT 2B receptors in preventing pilocarpine-induced status epilepticus in rats.

16. Morphological, Rheological and Electromagnetic Properties of Nanocarbon/Poly(lactic) Acid for 3D Printing: Solution Blending vs. Melt Mixing.

17. Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence.

18. LRRK2 activation in idiopathic Parkinson's disease.

19. 3D geophysical imaging for site-specific characterization plan of an old landfill.

20. Generation of three-dimensional human neuronal cultures: application to modeling CNS viral infections.

21. Dermatofibroma looks dermoscopically different on trunk versus extremities.

22. α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.

23. Zn(2+) -induced Ca(2+) release via ryanodine receptors triggers calcineurin-dependent redistribution of cortical neuronal Kv2.1 K(+) channels.

24. An investigation of thrust, depth and the impedance cardiogram as measures of cardiopulmonary resuscitation efficacy in a porcine model of cardiac arrest.

25. Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats.

26. Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.

27. Transient muscarinic and glutamatergic stimulation of neural stem cells triggers acute and persistent changes in differentiation.

28. Radiation dermatitis, burns, and recall phenomena: Meaningful instances of immunocompromised district.

29. A support vector machine for predicting defibrillation outcomes from waveform metrics.

31. Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation.

32. 5-HT2 receptors-mediated modulation of voltage-gated K+ channels and neurophysiopathological correlates.

33. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.

34. Evaluating 5-nitrofurans as trypanocidal agents.

35. DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress.

36. Thiol oxidation and altered NR2B/NMDA receptor functions in in vitro and in vivo pilocarpine models: implications for epileptogenesis.

37. A low tilt waveform in the transthoracic defibrillation of ventricular arrhythmias during cardiac arrest.

39. Redox sensitivity of tyrosine hydroxylase activity and expression in dopaminergic dysfunction.

40. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells.

41. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation.

42. Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults.

43. Mouse ES cells overexpressing DNMT1 produce abnormal neurons with upregulated NMDA/NR1 subunit.

44. Pilocapine alters NMDA receptor expression and function in hippocampal neurons: NADPH oxidase and ERK1/2 mechanisms.

45. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.

46. Mal de Meleda with hyperpigmented spots.

47. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.

49. Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1.

50. Changes in the frequency spectrum, the P-P interval, and the bispectral index during ventricular fibrillation are physiologic indicators of ventricular fibrillation duration.

Catalog

Books, media, physical & digital resources